Why are the research and testimonies of Vitamin B17 so hush-hush?
- 1 people answered
Edit Tags
Tags are used to find the best answers
You might also be interested in
treatment for tumor in the liver depends on the kind of tumor and its extent. please share your reports for a better advice.
Study findings on a potential link between breast size and breast cancer have been mixed. Some studies have found having a larger breast size increases risk, while others have found no link between breast size and risk but few studies have suggested that breast size increases risk among thin women,....
Early signs of cancer could be unexplained weight loss, a lump or swelling, unusual bleeding, persistent fatigue or changes in skin. Some people also notice long-lasting coughs or changes in bowel habits. If you experience any of these symptoms, it is recommended to consult the best oncologist avail....
Credihealth is not a medical practitioner and does not provide medical advice. You should consult your doctor or with a healthcare professional before starting any diet, exercise, supplementation or medication program. Know More
Reviewed by:Dr. Nitika Sharma - BDS
Reviewed by:Dr. Rakesh Kumar - MBBS, MS
Nidii Berwal
Vitamin B17 is not actually a vitamin. Vitamins are essential for human health. B17 is a poison also known as amygdalin as well as drugs. Amygdalin is broken down into cyanide, which is an incredibly toxic substance. There is zero reason to use it to treat cancer. There is no scientific evidence is works. It’s one of the clearest cases of snake oil medicine. This drug is a cyanogenic glycoside, a conjugate of cyanide and a sugar. They are a common type of chemical many plants produce for chemical self-defense: to keep their seeds from getting chewed up (apples, cherries, apricots, raw lima beans, bitter almonds) or seedlings eaten (sorghum) or roots eaten (cassava, processed to remove most of the cyanide in order to make tapioca). It was first experimented by former Soviet Union scientist in the 50’s of the 20th century and abandoned. The interest re-emerged in USA after Erns T. Krebs patented a method to synthesize a simplified version of the compound and started promoting it as treatment for cancer, it was utilized in many patients off-code until the FDA banned it.